Trial Profile
A Phase 1/2 Study of Mitoxantrone Hydrochloride Liposome Infusion in Patients With Non-Hodgkin's Lymphoma
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 11 Jul 2018
Price :
$35
*
At a glance
- Drugs Mitoxantrone liposomal (Primary)
- Indications Anaplastic large cell lymphoma; Diffuse large B cell lymphoma; Follicular lymphoma; Mantle-cell lymphoma; Non-Hodgkin's lymphoma; Peripheral T-cell lymphoma
- Focus Adverse reactions; Therapeutic Use
- Sponsors CSPC ZhongQi Pharmaceutical Technology
- 18 Aug 2016 Status changed from not yet recruiting to recruiting.
- 08 Aug 2016 New trial record